The current EVFM market cap is 2.72M. The company's latest EPS is USD 8.8019 and P/E is 0.11.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.81M | 2.46M | 5.11M | 4.84M | 3.6M |
Operating Income | -3.58M | -7.34M | -3.55M | -3.38M | -2.84M |
Net Income | -2.35M | -8.56M | 66.01M | -5.1M | -4.86M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 446k | 8.24M | 16.84M | 18.22M |
Operating Income | -52.74M | -103.62M | -166.8M | -84.12M | -17.85M |
Net Income | -80.03M | -142.31M | -206.24M | -78.01M | 50M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 26.03M | 14.07M | 13.32M | 10.55M | 8.22M |
Total Liabilities | 82.44M | 69.74M | 67.88M | 72.47M | 74.24M |
Total Equity | -56.4M | -55.66M | -56.36M | -66.51M | -70.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 28.3M | 109.97M | 42.51M | 25.16M | 10.55M |
Total Liabilities | 12.66M | 108.62M | 142.09M | 96.96M | 72.47M |
Total Equity | 15.64M | 1.35M | -104.32M | -71.8M | -66.51M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.94M | -6.43M | -8.8M | -8.97M | 123k |
Investing | -3k | -4k | -4k | -4k | -14k |
Financing | 1.7M | 2.3M | 4.44M | 4.78M | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -55.1M | -104.83M | -146.67M | -70.41M | -8.97M |
Investing | -8.12M | 6.23M | -2.69M | -341k | -4k |
Financing | 78.08M | 154.23M | 90.69M | 61.94M | 4.78M |
Market Cap | 2.72M |
Price to Earnings Ratio | 0.11 |
Price to Sales Ratio | 0.31 |
Price to Cash Ratio | 0 |
Price to Book Ratio | -0.09 |
Dividend Yield | - |
Shares Outstanding | 5.68M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0.64%) |
Company Name | Evofem Biosciences Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.evofem.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.